Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Crovalimab for Atypical Hemolytic Uremic Syndrome
Recruiting2 awardsPhase 3
Atlanta, Georgia
This trial is testing crovalimab, a medication that helps control the immune system, in children with a rare disease called aHUS. The goal is to see if it is safe and effective for these patients. Crovalimab works by calming down an overactive part of the immune system to prevent damage to the body. Another similar medication, eculizumab, has been used effectively to treat aHUS by inhibiting the complement system.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service